Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis

Multiple Sclerosis

Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis

JAMA Neurol.

Knier B, Leppenetier G, Wetzlmair C, Aly L, Hoshi MM, Pernpeintner V, Biberacher V, Berthele A, Mühlau M, Zimmer C, Hemmer B, Korn T

doi: 10.1001/jamaneurol.

SPECIAL REPORT

Multiple Sclerosis

Vaccination Readiness in Multiple Sclerosis

Multiple Sclerosis

Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy

Ann Neurol.

Sotirchos ES, Caldito NG, Filippatou A, Fitzgerald KC, Murphy OC, Lambe J, Nguyen J, Button J, Ogbuokiri E, Crainiceanu CM, Prince JL, Calabresi PA, Saidha S, International Multiple Sclerosis Visual System (IMSVISUAL) Consortium.

doi: 10.1002/ana.25738.

SPECIAL REPORT

Multiple Sclerosis

Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis

Perception of multiple sclerosis impact and treatment efficacy beliefs: mediating effect of patient's illness and self-appraisals

J Pain Symptom Manage.

Wilski M, Kocur P, Górny M, Koper M, Nadolska A, Chmielewski B, Tomczak M

doi: 10.1016/j.jpainsymman.

Multiple Sclerosis

Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.

J Neurol.

Kamm CP, Barin L, Gobbi C, Pot C, Calabrese P, Salmen A, Achtnichts L, Kesselring J, Puhan MA, von Wyl V, Swiss Multiple Sclerosis Registry (SMSR).

doi: 10.1007/s00415-019-09563-y.

Multiple Sclerosis

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

Brain.

Correale J, Gaitán MI, Ysrraelit MC, Fiol MP

doi: 10.1093/brain/aww258.

Multiple Sclerosis

Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis

Mult Scler.

Bsteh G, Berek K, Hegen H, Teuchner B, Buchmann A, Voortman MM, Auer M, Wurth S, Zinganell A, Di Pauli F, Deisenhammer F, Khalil M, Berger T

doi: 10.1177/1352458519882279.

Multiple Sclerosis

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis

Mult Scler.

Rolf L, Muris AH, Mathias A, Du Pasquier R, Koneczny I, Disanto G, Kuhle J, Ramagopalan S, Damoiseaux J, Smolders J, Hupperts R

doi: 10.1177/1352458517722646.

Related content

Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis

Vaccination Readiness in Multiple Sclerosis

Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy

Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis

Perception of multiple sclerosis impact and treatment efficacy beliefs: mediating effect of patient's illness and self-appraisals

Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis